-+ 0.00%
-+ 0.00%
-+ 0.00%

Kehua Biotech (002022.SZ) announced semi-annual results, with a net loss of 104 million yuan to mother

Zhitongcaijing·08/27/2026 14:25:07
Listen to the news

According to Zhitong Finance App News, Kehua Biotech (002022.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 838 million yuan, an increase of 5.54% over the previous year; net loss attributable to shareholders of listed companies of 104 million yuan; net loss of 114 million yuan attributable to shareholders of listed companies after deducting non-recurring profit and loss; and basic earnings per share -0.2017 yuan.